000 01353 a2200409 4500
005 20250514065912.0
264 0 _c20030623
008 200306s 0 0 eng d
022 _a1422-2795
024 7 _a10.1159/000064194
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoldrup, Claus
245 0 0 _aEthical, social and legal implications of pharmacogenomics: a critical review.
_h[electronic resource]
260 _bCommunity genetics
_c2001
300 _a204-14 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAttitude
650 0 4 _aBeneficence
650 0 4 _aControlled Clinical Trials as Topic
_xeconomics
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aGenetic Privacy
650 0 4 _aGenetic Testing
650 0 4 _aGovernment Agencies
650 0 4 _aHealth Care Costs
650 0 4 _aHumans
650 0 4 _aInformed Consent
650 0 4 _aOrphan Drug Production
650 0 4 _aPersonal Autonomy
650 0 4 _aPharmaceutical Preparations
_xeconomics
650 0 4 _aPharmacogenetics
_xeconomics
650 0 4 _aPrejudice
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aRisk Assessment
650 0 4 _aSocial Justice
773 0 _tCommunity genetics
_gvol. 4
_gno. 4
_gp. 204-14
856 4 0 _uhttps://doi.org/10.1159/000064194
_zAvailable from publisher's website
999 _c12539675
_d12539675